The pulmonary vascular complications of hereditary haemorrhagic telangiectasia

被引:90
作者
Faughnan, M. E. [1 ,2 ,3 ]
Granton, J. T. [4 ]
Young, L. H. [5 ]
机构
[1] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
[3] Univ Toronto, St Michaels Hosp, Div Respirol, Dept Med, Toronto, ON M5B 1W8, Canada
[4] Univ Toronto, Univ Hlth Network, Div Respirol, Dept Med, Toronto, ON M5B 1W8, Canada
[5] Yale Univ, Sch Med, Div Cardiovasc Med, Dept Med, New Haven, CT USA
关键词
Hereditary haemorrhagic telangiectasia; pulmonary arterial hypertension; pulmonary arteriovenous malformation; pulmonary hypertension; INTERSTITIAL LUNG-DISEASE; TO-LEFT SHUNT; ARTERIOVENOUS-MALFORMATIONS; ARTERIAL-HYPERTENSION; LIVER-TRANSPLANTATION; PORTOPULMONARY HYPERTENSION; CONTRAST ECHOCARDIOGRAPHY; JUVENILE POLYPOSIS; MUTATIONS; EMBOLOTHERAPY;
D O I
10.1183/09031936.00061308
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Hereditary haemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder, characterised by the presence of vascular malformations. The pulmonary vascular complications of HHT include pulmonary arteriovenous malformations, pulmonary hypertension associated with high-output heart failure and liver vascular malformations and, finally, pulmonary arterial hypertension secondary to HHT. In the present review, the authors describe the clinical presentation, diagnosis and management of all three pulmonary vascular presentations of HHT, as well as the underlying genetics and pathophysiology.
引用
收藏
页码:1186 / 1194
页数:9
相关论文
共 75 条
[1]   Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease [J].
Abdalla, SA ;
Letarte, M .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (02) :97-110
[2]   Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia [J].
Abdalla, SA ;
Gallione, CJ ;
Barst, RJ ;
Horn, EM ;
Knowles, JA ;
Marchuk, DA ;
Letarte, M ;
Morse, JH .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (03) :373-377
[3]   ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia [J].
Argyriou, L ;
Pfitzmann, R ;
Wehner, LE ;
Twelkemeyer, S ;
Neuhaus, P ;
Nayernia, K ;
Engel, W .
LIVER TRANSPLANTATION, 2005, 11 (09) :1132-1135
[4]  
BARANDA MM, 1984, ANGIOLOGY, V35, P568
[5]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[6]   Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: Mutations and manifestations [J].
Bayrak-Toydemir, P ;
McDonald, J ;
Markewitz, B ;
Lewin, S ;
Miller, F ;
Chou, LS ;
Gedge, F ;
Tang, W ;
Coon, H ;
Mao, R .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (05) :463-470
[7]   Pulmonary hypertension in interstitial lung disease [J].
Behr, J. ;
Ryu, J. H. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) :1357-1367
[8]   Transforming growth factor-βs and vascular disorders [J].
Bobik, Alex .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) :1712-1720
[9]   Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia [J].
Bonderman, D. ;
Nowotny, R. ;
Skoro-Sajer, N. ;
Adlbrecht, C. ;
Lang, I. M. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 :71-72
[10]   Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia:: Echo-color-Doppler vs multislice computed tomography study [J].
Buonamico, Paolo ;
Suppressa, Patrizia ;
Lenato, Gennaro M. ;
Pasculli, Giovanna ;
D'Ovidio, Francesco ;
Memeo, Maurizio ;
Scardapane, Arnaldo ;
Sabba, Carlo .
JOURNAL OF HEPATOLOGY, 2008, 48 (05) :811-820